Digipath to Expand Cannabis Testing Internationally
Digipath, Inc., a service-oriented independent testing laboratory, data acquisition and media firm focused on the developing cannabis and hemp markets, announced plans to expand internationally. Colombia is the first foreign market in which Digipath plans to provide cannabis testing for both local consumers and cannabis exporters.
Due to its climate and low cost of production, Colombia is projected to be a significant cannabis exporter. And all cannabis products will need to be tested for potency and safety prior to export to any other country.
Colombia formally legalized medical marijuana in 2015 and has realigned its interests to the export market in its current policy operations.
Digipath has retained legal representation in Colombia, hired a local operations manager and is evaluating potential locations.
“We expect Colombia to be one of the market leaders in cannabis, hemp and CBD production and are excited about the possibilities,” said Todd Denkin, Digipath CEO.
Through Digipath’s work in Nevada, the company’s labs helped pioneer cannabis lab testing protocols and implement stringent safety regulations. The company intends to carry the testing standards it has developed in Nevada into these new international markets.
